Literature DB >> 25469011

Causes and consequences of microsatellite instability in gastric carcinogenesis.

Sérgia Velho1, Maria Sofia Fernandes1, Marina Leite1, Ceu Figueiredo1, Raquel Seruca1.   

Abstract

Loss of DNA mismatch repair (MMR) function, due to somatic or germline epi/genetic alterations of MMR genes leads to the accumulation of numerous mutations across the genome, creating a molecular phenotype known as microsatellite instability (MSI). In gastric cancer (GC), MSI occurs in about 15% to 30% of the cases. This review summarizes the current knowledge on the molecular mechanisms underlying the acquisition of MSI in GC as well as on the clinic, pathologic and molecular consequences of the MSI phenotype. Additionally, current therapeutic strategies for GC and their applicability in the MSI subset are also discussed.

Entities:  

Keywords:  Gastric cancer; Helicobacter pylori; Microsatellite instability; Mismatch repair genes; Oncogenes

Mesh:

Substances:

Year:  2014        PMID: 25469011      PMCID: PMC4248186          DOI: 10.3748/wjg.v20.i44.16433

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  118 in total

1.  Tumors with microsatellite instability: many mutations, targets and paradoxes.

Authors:  Manuel Perucho
Journal:  Oncogene       Date:  2003-04-17       Impact factor: 9.867

Review 2.  KRAS signaling pathway alterations in microsatellite unstable gastrointestinal cancers.

Authors:  Sérgia Velho; Giovanni Corso; Carla Oliveíra; Raquel Seruca
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

3.  Chemosensitivity and survival in gastric cancer patients with microsatellite instability.

Authors:  Eiji Oki; Yoshihiro Kakeji; Yan Zhao; Rintaro Yoshida; Koji Ando; Takanobu Masuda; Kippei Ohgaki; Masaru Morita; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2009-06-30       Impact factor: 5.344

4.  Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.

Authors:  Masanori Terashima; Koji Kitada; Atsushi Ochiai; Wataru Ichikawa; Issei Kurahashi; Shinichi Sakuramoto; Hitoshi Katai; Takeshi Sano; Hiroshi Imamura; Mitsuru Sasako
Journal:  Clin Cancer Res       Date:  2012-09-12       Impact factor: 12.531

5.  High microsatellite instability predicts good prognosis in intestinal-type gastric cancers.

Authors:  Hyunki Kim; Ji Yeong An; Sung Hoon Noh; Sung Kwan Shin; Yong Chan Lee; Hoguen Kim
Journal:  J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 4.029

Review 6.  Helicobacter pylori infection generates genetic instability in gastric cells.

Authors:  Ana Manuel Dantas Machado; Céu Figueiredo; Raquel Seruca; Lene Juel Rasmussen
Journal:  Biochim Biophys Acta       Date:  2010-02-01

7.  Somatic mutations in mismatch repair genes in sporadic gastric carcinomas are not a cause but a consequence of the mutator phenotype.

Authors:  Mafalda Pinto; Ying Wu; Rob G J Mensink; Luís Cirnes; Raquel Seruca; Robert M W Hofstra
Journal:  Cancer Genet Cytogenet       Date:  2008-01-15

8.  Helicobacter pylori infection and expression of DNA mismatch repair proteins.

Authors:  Vahid Mirzaee; Mahsa Molaei; Hamid-Mohaghegh Shalmani; Mohammad-Reza Zali
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

9.  Mutations of PIK3CA in gastric adenocarcinoma.

Authors:  Vivian Sze Wing Li; Chi Wai Wong; Tsun Leung Chan; Agnes Sze Wah Chan; Wei Zhao; Kent-Man Chu; Samuel So; Xin Chen; Siu Tsan Yuen; Suet Yi Leung
Journal:  BMC Cancer       Date:  2005-03-23       Impact factor: 4.430

10.  Epidermal growth factor receptor structural alterations in gastric cancer.

Authors:  Cátia Moutinho; Ana R Mateus; Fernanda Milanezi; Fátima Carneiro; Raquel Seruca; Gianpaolo Suriano
Journal:  BMC Cancer       Date:  2008-01-16       Impact factor: 4.430

View more
  31 in total

1.  The involvement of survivin in insulin-like growth factor 1-induced epithelial-mesenchymal transition in gastric cancer.

Authors:  Chengjun Li; Jinbao Li; Dawei Wu; Gang Han
Journal:  Tumour Biol       Date:  2015-08-14

Review 2.  Next generation sequencing-based emerging trends in molecular biology of gastric cancer.

Authors:  Renu Verma; Prakash C Sharma
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

Review 3.  Recognition of and recent issues in hereditary diffuse gastric cancer.

Authors:  Shinya Sugimoto; Hirokazu Komatsu; Yuichi Morohoshi; Takanori Kanai
Journal:  J Gastroenterol       Date:  2015-06-07       Impact factor: 7.527

Review 4.  Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

Review 5.  [Current biomarkers for gastric cancer].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

6.  Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features.

Authors:  Kyung-Ju Kim; Hae Yoen Jung; Mee-Hye Oh; Hyundeuk Cho; Ji-Hye Lee; Hyun Ju Lee; Si-Hyong Jang; Moon Soo Lee
Journal:  J Gastric Cancer       Date:  2015-09-30       Impact factor: 3.720

7.  C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer.

Authors:  Yonggang Yang; Chunyan Yang; Jianping Zhang
Journal:  Med Oncol       Date:  2015-02-20       Impact factor: 3.064

8.  CCR7 pathway induces epithelial-mesenchymal transition through up-regulation of Snail signaling in gastric cancer.

Authors:  Jianping Zhang; Yunzhe Zhou; Yonggang Yang
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

Review 9.  Molecular background of the regional lymph node metastasis of gastric cancer.

Authors:  Tong Zhu; Xueqian Hu; Pinkang Wei; Guangzhi Shan
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

Review 10.  Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer.

Authors:  Dionisia Quiroga; H Kim Lyerly; Michael A Morse
Journal:  Curr Treat Options Oncol       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.